193 related articles for article (PubMed ID: 11596015)
1. Primary hepatic lymphoma: favorable outcome after combination chemotherapy.
Page RD; Romaguera JE; Osborne B; Medeiros LJ; Rodriguez J; North L; Sanz-Rodriguez C; Cabanillas F
Cancer; 2001 Oct; 92(8):2023-9. PubMed ID: 11596015
[TBL] [Abstract][Full Text] [Related]
2. Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma.
De Renzo A; Perna F; Persico M; Notaro R; Mainolfi C; de Sio I; Ciancia G; Picardi M; Del Vecchio L; Pane F; Rotoli B
Eur J Haematol; 2008 Jul; 81(1):51-7. PubMed ID: 18397390
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment.
Iannitto E; Ammatuna E; Tripodo C; Marino C; Calvaruso G; Florena AM; Montalto G; Franco V
Hematol J; 2004; 5(6):530-3. PubMed ID: 15570298
[TBL] [Abstract][Full Text] [Related]
4. Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection.
Möhler M; Gutzler F; Kallinowski B; Goeser T; Stremmel W
Dig Dis Sci; 1997 Nov; 42(11):2241-5. PubMed ID: 9398801
[TBL] [Abstract][Full Text] [Related]
5. Lymphoma of the liver: Clinicopathological features of 19 patients.
Peng Y; Qing AC; Cai J; Yue C; French SW; Qing X
Exp Mol Pathol; 2016 Apr; 100(2):276-80. PubMed ID: 26859783
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological and survival features of primary hepatic lymphoma: an analysis of 35 cases].
Zhao Q; Liu HP; Gu YJ; Cong WM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):689-92. PubMed ID: 24332057
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.
Besson C; Canioni D; Lepage E; Pol S; Morel P; Lederlin P; Van Hoof A; Tilly H; Gaulard P; Coiffier B; Gisselbrecht C; Brousse N; Reyes F; Hermine O;
J Clin Oncol; 2006 Feb; 24(6):953-60. PubMed ID: 16418500
[TBL] [Abstract][Full Text] [Related]
8. Primary non-Hodgkin's lymphoma of the liver: sonographic and CT findings.
Lu Q; Zhang H; Wang WP; Jin YJ; Ji ZB
Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):75-81. PubMed ID: 25655294
[TBL] [Abstract][Full Text] [Related]
9. Primary lymphoma of the liver. Ten cases and a review of the literature.
Osborne BM; Butler JJ; Guarda LA
Cancer; 1985 Dec; 56(12):2902-10. PubMed ID: 3840404
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic features and treatment outcomes of primary hepatic lymphoma: a report of four cases].
Zhang YJ; Chen MS; Liang HH; Xu L; Zhang YQ
Ai Zheng; 2005 Mar; 24(3):365-7. PubMed ID: 15757544
[TBL] [Abstract][Full Text] [Related]
11. Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
Morel P; Dupriez B; Herbrecht R; Bastion Y; Tilly H; Delannoy A; Haioun C; Nouvel C; Bouabdallah K; Baumelou E
Br J Cancer; 1994 Jul; 70(1):154-9. PubMed ID: 7517172
[TBL] [Abstract][Full Text] [Related]
12. Complete response to chemotherapy in primary hepatic lymphoma.
Zafar MS; Aggarwal S; Bhalla S
J Cancer Res Ther; 2012; 8(1):114-6. PubMed ID: 22531527
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
Sarris AH; Braunschweig I; Medeiros LJ; Duvic M; Ha CS; Rodriguez MA; Hagemeister FB; McLaughlin P; Romaguera J; Cox J; Cabanillas F
J Clin Oncol; 2001 Jan; 19(2):398-405. PubMed ID: 11208831
[TBL] [Abstract][Full Text] [Related]
14. Primary non-Hodgkin lymphoma of the cranial vault.
Naama O; Gazzaz M; Boucetta M; Elmoustarchid B
Rev Neurol (Paris); 2017 Dec; 173(10):668-670. PubMed ID: 28629635
[No Abstract] [Full Text] [Related]
15. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
17. Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era.
Zaky AH; Bakry R; El-sayed MI; Elwanis MA; Nabih O
Hematology; 2014 Oct; 19(7):412-6. PubMed ID: 24620947
[TBL] [Abstract][Full Text] [Related]
18. Primary non-Hodgkin's lymphoma of the liver.
Noronha V; Shafi NQ; Obando JA; Kummar S
Crit Rev Oncol Hematol; 2005 Mar; 53(3):199-207. PubMed ID: 15718146
[TBL] [Abstract][Full Text] [Related]
19. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
Touroutoglou N; Dimopoulos MA; Younes A; Hess M; Pugh W; Cox J; Cabanillas F; Sarris AH
J Clin Oncol; 1995 Jun; 13(6):1361-7. PubMed ID: 7751880
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphoma.
Tomita N; Kodama F; Takabayashi M; Kawano T; Yamaji S; Fujimaki K; Fujisawa S; Kanamori H; Motomura S; Ishigatsubo Y
Leuk Lymphoma; 2003 Jul; 44(7):1159-64. PubMed ID: 12916868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
